Open AccessINFERIOR OUTCOMES OF BASILIXIMAB COMPARE TO ANTI-THYMOCYTE GLOBULIN INDUCTION THERAPY IN KIDNEY TRANSPLANTATION WITH WEAK PRETRANSPLANT DONOR SPECIFIC ANTI-HLA ANTIBODY
TransplantationHyunmin Ko +62020Journals
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support